↓ Skip to main content

Dove Medical Press

Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria

Overview of attention for article published in Drug Design, Development and Therapy, March 2017
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter
3 X users
patent
1 patent

Citations

dimensions_citation
108 Dimensions

Readers on

mendeley
141 Mendeley
Title
Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria
Published in
Drug Design, Development and Therapy, March 2017
DOI 10.2147/dddt.s107195
Pubmed ID
Authors

Xiaozhe Wu, Zhan Li, Xiaolu Li, Yaomei Tian, Yingzi Fan, Chaoheng Yu, Bailing Zhou, Yi Liu, Rong Xiang, Li Yang

Abstract

Antibiotic-resistant bacteria present a great threat to public health. In this study, the synergistic effects of antimicrobial peptides (AMPs) and antibiotics on several multidrug-resistant bacterial strains were studied, and their synergistic effects on azithromycin (AZT)-resistance genes were analyzed to determine the relationships between antimicrobial resistance and these synergistic effects. A checkerboard method was used to evaluate the synergistic effects of AMPs (DP7 and CLS001) and several antibiotics (gentamicin, vancomycin [VAN], AZT, and amoxicillin) on clinical bacterial strains (Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter baumannii, and Escherichia coli). The AZT-resistance genes (ermA, ermB, ermC, mefA, and msrA) were identified in the resistant strains using quantitative polymerase chain reaction. For all the clinical isolates tested that were resistant to different antibiotics, DP7 had high antimicrobial activity (≤32 mg/L). When DP7 was combined with VAN or AZT, the effect was most frequently synergistic. When we studied the resistance genes of the AZT-resistant isolates, the synergistic effect of DP7-AZT occurred most frequently in highly resistant strains or strains carrying more than two AZT-resistance genes. A transmission electron microscopic analysis of the S. aureus strain synergistically affected by DP7-AZT showed no noteworthy morphological changes, suggesting that a molecular-level mechanism plays an important role in the synergistic action of DP7-AZT. AMP DP7 plus the antibiotic AZT or VAN is more effective, especially against highly antibiotic-resistant strains.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 141 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 141 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 22 16%
Student > Master 22 16%
Student > Bachelor 19 13%
Student > Ph. D. Student 15 11%
Student > Doctoral Student 6 4%
Other 18 13%
Unknown 39 28%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 32 23%
Agricultural and Biological Sciences 11 8%
Pharmacology, Toxicology and Pharmaceutical Science 10 7%
Chemistry 7 5%
Engineering 7 5%
Other 22 16%
Unknown 52 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 February 2019.
All research outputs
#7,780,614
of 25,382,440 outputs
Outputs from Drug Design, Development and Therapy
#525
of 2,268 outputs
Outputs of similar age
#116,655
of 324,443 outputs
Outputs of similar age from Drug Design, Development and Therapy
#15
of 50 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 324,443 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.